Financial Disclosures - PPPC

Roy S. Chuck, MD, PhD, Chair
Microcures, TECLens - C
Microcures, TECLens - O
Albert Einstein COM/Montefiore Medical Center - P
University of California - P

Christina J. Flaxel, MD
No financial relationships to disclose

Francis S. Mah, MD
Abbott Medical Optics, Inc., Bausch Lomb, Novartis, Alcon Pharmaceuticals, Sun Pharma - L
Abbott Medical Optics, Inc., Aerie, Alcon Laboratories, Inc., Allergan, Avedro, Inc., Avellino Labs, Bausch Lomb, EyePoint, iView, KALA Pharmaceuticals, Mallinckrodt Pharmaceuticals, NovaBay, Novartis, Alcon Pharmaceuticals, Ocular Science, Ocular Therapeutix, Okogen, Omeros Corporation, PolyActiva, Slack Publishing, Sun Pharma, Sydnexis, TearLab - C
Slack Publishing - P
Ocular Science, Okogen, Sydnexis - O
Abbott Medical Optics, Inc., Ocular Therapeutix - S

Steven J. Gedde, MD
No financial relationships to disclose

Kevin M. Miller, MD
Alcon Laboratories, Inc., Johnson & Johnson Vision, LENSAR, Oculus, Inc. - C
Abbvie - US
Johnson & Johnson Vision - S

Thomas A. Oetting, MD
No financial relationships to disclose

Divya M. Varu, MD
No financial relationships to disclose

David K. Wallace, MD, MPH
National Eye Institute - S

David C. Musch, PhD, MPH, Methodologist
Applied Genetics Technologies Corporation, ClinReg Consulting, Editas, Lundbeck, ONL Therapeutics, Regulatory Pathway Groups, Inc. - C 
Centers for Disease Control, National Eye Institute - S

 KEY:

C = Consultant/Advisor (consultant fee, paid advisory boards or fees for attending a meeting [for the past 1 year])
E = Employee (employed by a commercial entity)
L = Lecture Fees (lecture fees [honoraria], travel fees or reimbursement when speaking at the invitation of a commercial entity
O = Equity Owner
S = Grant Support
P = Patents/Royalties
US = Equity/Stock Options Holder - Public Corp